FDA Inspection 789010 — TriRx Segre
The FDA completed an inspection of TriRx Segre on Jun 15, 2012 in Segre-En-Anjou Bleu. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jun 15, 2012
- Fiscal Year
- 2012
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Segre-En-Anjou Bleu (France)
Citations
| ID | CFR | Description |
|---|---|---|
| 1215 | 21 CFR 211.67(b) | Written procedures not established/followed |
| 1433 | 21 CFR 211.42(c)(10)(iii) | Air Supply |
| 1890 | 21 CFR 211.165(e) | Test methods |
| 3545 | 21 CFR 211.44 | Adequate lighting not provided |